Sign in

CIK 0001159036

  • Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880488686
Phone
+1 858-794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
  1. 4 Planned sale SVP, CHIEF TECHNICAL OFFICER sold 20,000 shares at an average $53.50 ($1,070,059)
  2. 4 Planned sale PRESIDENT AND CEO sold 20,000 shares at an average $53.29 ($1,065,743)
  3. 4 Planned sale PRESIDENT AND CEO sold 30,000 shares at an average $56.88 ($1,706,440)
  4. 4 Planned sale SVP, CHIEF TECHNICAL OFFICER sold 20,000 shares at an average $62.45 ($1,249,096)
  5. 4 Planned sale PRESIDENT AND CEO sold 30,000 shares at an average $59.13 ($1,773,790)
  6. 4 Exercise or conversion SVP, CHIEF TECHNICAL OFFICER acquired 5,580 shares (option exercise)
  7. 4 Planned sale SVP, CHIEF TECHNICAL OFFICER sold 20,000 shares at an average $61.40 ($1,228,020)
  8. 4 Planned sale PRESIDENT AND CEO sold 30,000 shares at an average $57.15 ($1,714,451)
  9. 4 Open-market sale Director sold 29,881 shares at an average $56.53 ($1,689,294)
  10. 4 Planned sale SVP, CHIEF TECHNICAL OFFICER sold 20,000 shares at an average $55.00 ($1,100,023)
  11. 4 Planned sale SVP, CHIEF FINANCIAL OFFICER sold 5,000 shares at an average $53.93 ($269,662)
  12. 4 Planned sale SVP, CHIEF FINANCIAL OFFICER sold 30,000 shares at an average $51.93 ($1,557,940)
  13. 4 Planned sale SVP, CHIEF TECHNICAL OFFICER sold 10,000 shares at $49.43 ($494,260)
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale Director sold 20,000 shares at an average $50.32 ($1,006,300)
  16. 4 Planned sale SVP, CHIEF TECHNICAL OFFICER sold 20,000 shares at an average $45.27 ($905,480)
  17. 4 Grant or award Director acquired 6,501 shares (grant or award)
  18. 4 Grant or award Director acquired 6,501 shares (grant or award)
  19. 4 Grant or award Director acquired 6,501 shares (grant or award)
  20. 4 Grant or award Director acquired 6,501 shares (grant or award)

Page 6 of 39 · 774 filings